No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CORT Corcept Therapeutics
- 34.570
- +0.690+2.04%
Close Jul 22 16:00 ET
- 34.970
- +0.400+1.16%
Post 17:14 ET
3.60BMarket Cap32.92P/E (TTM)
34.771High33.880Low811.32KVolume34.300Open33.880Pre Close27.91MTurnover0.96%Turnover Ratio36.78P/E (Static)104.11MShares35.22052wk High6.57P/B2.94BFloat Cap20.84052wk Low--Dividend TTM85.00MShs Float35.220Historical High--Div YieldTTM2.63%Amplitude0.680Historical Low34.396Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
Zacks.com Featured Highlights Include ADMA Biologics, American Superconductor, Biote, Lincoln Educational Services and Corcept Therapeutics
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Corcept Therapeutics (CORT) and Pfizer (PFE)
Is Corcept Therapeutics Incorporated's (NASDAQ:CORT) Recent Stock Performance Tethered To Its Strong Fundamentals?
Most readers would already be aware that Corcept Therapeutics' (NASDAQ:CORT) stock increased significantly by 35% over the past three months. Given that the market rewards strong financials in the
Truist Financial Reaffirms Their Buy Rating on Corcept Therapeutics (CORT)
High Insider Ownership Growth Companies On US Exchanges In July 2024
Comments
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg